ARCHIVES

DCE Advisors OK Recompetitions Worth $10 Mil.

This article is from The Cancer Letter archive.

Vol. 17 No. 29 | July 19, 1991

Download PDF Visit The Full Archive

Related Articles

It is The First FDA Withdrawl Of An Accelerated Approval

November 18, 2011

ASCO Briefing Highlights Seven Studies That Could Change Clinical Practice

May 29, 2009

From Long Island To Houston By Rental Care, In 43 Hours.

October 5, 2001

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

December 10, 1999

Emphasis On Early Disease In Clinical Trials, Early Lung Cancer Detection Seen As “Landmark”

September 19, 1975